Cingulate Inc
General ticker "CING" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $7.5M
Cingulate Inc does not follow the US Stock Market performance with the rate: -33.1%.
Estimated limits based on current volatility of 4.4%: low 4.13$, high 4.52$
Factors to consider:
- Current price 77.1% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [20.81$, 116.52$]
- 2024-12-30 to 2025-12-30 estimated range: [6.75$, 36.42$]
Financial Metrics affecting the CING estimates:
- Negative: Non-GAAP EPS, $ of -301.11 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -81.18 <= 2.35
- Negative: Industry earnings per price (median), % of -15.01 <= 1.31
- Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
- Negative: negative Net income
Short-term CING quotes
Long-term CING plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $20.68MM | $17.50MM | $22.76MM |
| Operating Income | $-20.68MM | $-17.50MM | $-22.76MM |
| Non-Operating Income | $-0.03MM | $-0.17MM | $-0.78MM |
| Interest Expense | $0.00MM | $0.17MM | $0.00MM |
| R&D Expense | $8.41MM | $9.00MM | $15.49MM |
| Income(Loss) | $-20.71MM | $-17.68MM | $-23.53MM |
| Profit(Loss) | $-20.71MM | $-17.68MM | $-23.53MM |
| Stockholders Equity | $20.84MM | $3.88MM | $-6.87MM |
| Inventory | $0.00MM | $0.10MM | $0.01MM |
| Assets | $22.89MM | $11.41MM | $3.49MM |
| Operating Cash Flow | $-10.43MM | $-15.88MM | $-15.04MM |
| Capital expenditure | $0.81MM | $0.15MM | $0.00MM |
| Investing Cash Flow | $-0.81MM | $-0.15MM | $-0.22MM |
| Financing Cash Flow | $26.54MM | $4.90MM | $9.96MM |
| Earnings Per Share* | $-440.14 | $-378.81 | $-311.99 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.